WaveMan
WaveMan · Company
GIPL · Global Innovative Platforms Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

GIPL Global Innovative Platforms (GIPL) Insider Trading, Ownership & Congress Trades

Medical Devices · Surgical & medical instruments & apparatus · CIK 0001837774
Quote by TradingView
SEC filings
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter

What the filings say about GIPL

Insiders, 180 days
+$1.2K net bought
1 buyer

Global Innovative Platforms insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Global Innovative Platforms Inc. insiders bought a net $1.2K of stock across 3 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
BROWN DAVID A B
BUY
2026-09-10 SECtraded 2026-09-08
2,500
$1.2K
+0.0%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Sep 27, 2024.
  • The trade is 0.0% of the 6,778,112 shares held after it.
  • No other insider bought within 30 days.
Insider activity: Insider BROWN DAVID A B bought about $1.2K of GIPL on Sep 8, 2026.
Brown Andrew Nicholas
CEO and CFO
BUY
2026-06-15 SECtraded 2026-03-31
250,000
$30.0K
+0.0%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 23.1% of the 1,081,055 shares held after it.
  • No other insider bought within 30 days.
Insider activity: CEO and CFO Brown Andrew Nicholas bought about $30.0K of GIPL on Mar 31, 2026, the largest insider purchase at the company since 2024.
BROWN DAVID A B
BUY
2026-06-04 SECtraded 2024-09-27
2,000,000
$200.0K
+0.0%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 33.2% of the 6,025,612 shares held after it.
  • No other insider bought within 30 days.
Insider activity: Insider BROWN DAVID A B bought about $200.0K of GIPL on Sep 27, 2024, the largest insider purchase at the company on our record.
3 transactions on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net +$1.2K over 180 days
+$1.2K over 90 days · +$1.2K of it by a 10%+ holder
more than 64% of Medical Devices
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
no short interest reported
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch GIPL

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-37.5%12M
-86%-50%-13%+24%2025-102025-122026-022026-042026-062026-082026-10 2026-03-31 · Brown Andrew Nicholas bought $30.0K2026-09-08 · BROWN DAVID A B bought $1.2K
Insider buy
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns GIPL: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in GIPL

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

GIPL planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $1.2K bought by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
PENBLFSMTDSIBNWRBYISRGTXGDXCMEWTMDXOMIRMD

GIPL financials

Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$187.2K
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
n/a
revenue under $1M, the ratio says nothing
Free cash flow, TTM
n/a
capex not filed for the four quarters
Debt to equity
0.01x
current debt only, 2026-06-30; equity 2026-06-30
Cash flow to debt
-59.69x
TTM operating cash flow over current debt only, 2026-06-30
Return on equity
-190.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-180.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on capital employed
-190.0%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$24.6M
market value at close 2026-10-26 on 2026-08-04 shares, plus current debt only, 2026-06-30, minus cash 2026-06-30
FCF yield
n/a
capex not filed for the four quarters
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-092024-092023-092022-09
Revenue$0$0$0$0
Operating income-$718.3K-$136.2K-$282.8K-$53.8K
Net income-$718.3K-$136.2K-$282.8K-$53.8K
EPS (diluted)-0.02-0.01-0.46-0.08
Operating cash flow-$560.7K-$87.4K-$234.8K-$53.6K
Cash$17.8Kn/an/an/a
SEC XBRL, fiscal years, as known on 2026-10-28

GIPL Stock Sonar score 4/7 axes

Find similar shapesCompare

GIPL ranks highest on insider conviction (57th percentile) and financial health (44th), and lowest on risk and compliance (1st), among Medical Devices peers.

Profitability
11
Inputs
  • Return on equity-190.0% · 15 pct, sector of 183
  • Return on assets-180.9% · 8 pct, sector of 214
  • Return on invested capitaltax provision or pre-tax income not filed for the four quarters
  • Return on capital employed-190.0% · 9 pct, sector of 188
Financial health
44
Inputs
  • Debt to equity0.01x · 85 pct, sector of 159
  • Cash flow to debt-59.69x · 3 pct, sector of 150
Insider conviction
57
Inputs
  • Net Form 4 buying (codes P and S), 180d$1K · 63 pct, sector of 140
  • Insider buyers, 180d1 · 52 pct, sector of 142
Risk and compliance
1
Inputs
  • Short interest, % of floatno short interest or no free float on file
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-K+52.8% · 1 pct, sector of 198
3 not measured: Growth, Institutional and government, US patents
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

GIPL filings, in plain words

Are Global Innovative Platforms insiders buying or selling GIPL?

In the 180 days to 2026-10-28, Global Innovative Platforms insiders were net buyers, a net $1.2K across purchases and sales reported on Form 4, by 1 buyer.

Read the full summary

In the 180 days to 2026-10-28, Global Innovative Platforms insiders were net buyers of GIPL, a net $1.2K across purchases and sales reported on Form 4 by 1 buyer. Most of that figure, $1.2K, came from a holder of 10% or more rather than an officer or director. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies